![](https://weeklysauce.com/wp-content/uploads/2021/09/image-2655137241.jpg)
A drug previously approved for multiple sclerosis also can treat inflammatory bowel disease in some patients, a new clinical trial reports. The medication, ozanimod (Zeposia), proved effective in helping patients with ulcerative colitis, sending many into full remission, according to results being published Sept. 30 in the New England Journal of Medicine. Ulcerative colitis is… read on > read on >